| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Jan 17, 2024 | Sale | $17.23 | 9,786 | 168,613 | 185,069 | Jan 19, 2024, 05:19 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Aug 04, 2023 | Option Exercise | $14.54 | 28,841 | 419,486 | 214,905 | Aug 07, 2023, 08:50 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Aug 03, 2023 | Option Exercise | $18.06 | 16,669 | 301,124 | 207,914 | Aug 07, 2023, 08:50 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Jul 17, 2023 | Sale | $18.01 | 17,937 | 323,029 | 219,183 | Jul 19, 2023, 08:26 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Mar 30, 2023 | Sale | $26.52 | 9,036 | 239,643 | 201,964 | Apr 03, 2023, 06:51 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Dec 20, 2022 | Sale | $19.10 | 8,748 | 167,108 | 138,191 | Dec 21, 2022, 09:32 PM | |
| PLRX | PLIANT THERAPEUTICS, INC. | Hull Hans | Chief Business Officer | Dec 30, 2020 | Option Exercise | $2.08 | 3,500 | 7,280 | 120,746 | Jan 04, 2021, 08:00 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Hull Hans | SVP, Business Operations | Jun 12, 2015 | Option Exercise | $0.19 | 8,300 | 1,577 | 19,620 | Jun 16, 2015, 06:25 PM | |
| [AAVL] | Avalanche Biotechnologies, Inc. | Hull Hans | SVP, Business Operations | Jun 04, 2015 | Option Exercise | $18.92 | 4,000 | 75,663 | 13,320 | Jun 05, 2015, 05:59 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Hull Hans | SVP, Business Operations | May 04, 2015 | Option Exercise | $15.53 | 10,000 | 155,299 | 16,320 | May 06, 2015, 04:06 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Hull Hans | SVP, Business Operations | Apr 07, 2015 | Sale | $19.40 | 55,000 | 1,066,798 | 30,820 | Apr 08, 2015, 04:32 PM |
Menu